Skin substitutes and advanced wound care have quietly become one of the most aggressive enforcement areas in federal health care fraud. What began as civil audits and payment reviews has increasingly evolved into subpoenas, False Claims Act cases, and criminal investigations.
I expect this trend to accelerate in 2026.
In my practice, I am seeing more providers contacted by auditors or investigators asking questions that clearly go beyond routine billing issues. Many are surprised by how quickly a wound care review can escalate into a serious legal matter.
This article explains why skin substitutes and wound care are under scrutiny, what the government is focusing on, and what providers should do if they receive an audit letter, subpoena, or investigative inquiry.
What Are Skin Substitutes and Why Are They Under Scrutiny?
Skin substitutes—also referred to as cellular and tissue-based products—are commonly used in the treatment of chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure injuries. These products can be expensive, and reimbursement rates can be significant.
From an enforcement perspective, that combination raises red flags.
Federal agencies, including the Department of Justice and the Department of Health and Human Services Office of Inspector General, have repeatedly identified wound care and skin substitute billing as areas vulnerable to fraud, waste, and abuse. DOJ press releases over the last several years reflect a growing number of settlements and prosecutions involving alleged overutilization, lack of medical necessity, and improper financial relationships.
Why Enforcement Is Increasing
There are several reasons skin substitutes and wound care clinics have become a focus:
1. High reimbursement and rapid growth
Skin substitute billing expanded rapidly, particularly in outpatient and office-based settings. Sudden spikes in utilization—especially when tied to a small group of products—often trigger audits.
2. Documentation and medical necessity issues
Many investigations center on whether wounds met criteria for advanced biologic treatment, whether conservative care was attempted first, and whether documentation supports repeated applications.
3. Manufacturer and distributor relationships
The government is closely examining relationships between providers and product manufacturers, including consulting agreements, free product arrangements, and other financial incentives that may implicate the Anti-Kickback Statute.
4. Contractor data analytics
Medicare contractors now use sophisticated data analysis to identify outliers. Providers may be flagged without any patient complaint or whistleblower involvement.
Red Flags Giving Rise to Investigations
While every case is different, the same issues appear repeatedly:
- High volume use of a single skin substitute product
- Repeated applications without documented improvement
- Identical or templated wound measurements
- Billing across multiple anatomic sites in short timeframes
- Inadequate documentation of conservative treatment attempts
- Financial arrangements with manufacturers or sales representatives
Importantly, these red flags often surface first in civil audits, not criminal investigations—yet they can later become the basis for criminal allegations.
Civil vs. Criminal Exposure: Why Early Strategy Matters
Not every wound care review becomes a criminal case. But many criminal health care fraud cases start as civil audits or False Claims Act investigations.
Civil exposure may include:
- Overpayment demands
- False Claims Act liability
- Civil monetary penalties
- Exclusion from federal health care programs
Criminal exposure may include:
- Health care fraud charges
- Conspiracy allegations
- Anti-kickback violations
- Wire fraud and false statement counts
The way a provider responds early—especially during audits, interviews, or subpoena responses—can significantly affect whether a case stays civil or escalates.
What to Do If You Receive an Audit Letter or Subpoena
If you receive:
- A Medicare audit request
- A UPIC or SMRC letter
- A subpoena from DOJ or a U.S. Attorney’s Office
- Contact from federal agents
do not assume it is “just billing.”
At that point:
- Communications are evidence
- Documentation choices matter
- Statements to auditors or agents can be used later
Early legal advice can help control the narrative, preserve defenses, and avoid unnecessary exposure.
How Defense Counsel Approaches These Cases
Effective defense in skin substitute and wound care matters requires understanding both:
- the medical framework of wound care, and
- the enforcement priorities driving government decisions.
Defense strategy often focuses on:
- medical necessity standards
- clinical judgment vs. hindsight bias
- documentation realities in wound care settings
- distinguishing aggressive treatment from fraudulent intent
- managing parallel civil and criminal risk
Conclusion
Skin substitute and wound care investigations are not going away. Providers who understand the enforcement landscape—and respond thoughtfully when issues arise—are in a far better position than those who react defensively or delay getting advice.
If your practice is facing scrutiny related to wound care or skin substitute billing, early guidance matters.
